Buy Ellansé
Showing all 2 results
-


ELLANSÉ™ M
$ 280.00 Add To Cart-+

ELLANSÉ™ S
$ 349.00 Add To Cart-+Aesthetic practitioners looking to buy Ellansé can source the full range through Direct Doctor Supply. Developed by Sinclair Pharma, Ellansé is a CE-marked polycaprolactone (PCL)-based collagen stimulator filler that combines immediate volumisation with sustained neocollagenesis in a single injectable treatment. Available in four duration variants — Ellansé-S, Ellansé-M, Ellansé-L, and Ellansé-E — each calibrated to a different longevity profile, the Ellansé filler range gives practitioners genuine flexibility when planning collagen stimulator treatments for diverse patient populations. Direct Doctor Supply has been a trusted wholesale supplier to licensed aesthetic professionals since 2014, offering competitive pricing and dependable fulfilment. Browse the catalogue below to find the right variant for the clinic.
Most Popular Ellansé Products
Ellansé-S
Ellansé-S provides approximately one year of volumisation and collagen stimulation, making it the most accessible entry point for patients new to PCL-based biostimulatory treatment.[1] Its shorter duration allows practitioners and patients to evaluate tolerance, aesthetic response, and treatment goals before progressing to longer-lasting options. This flexibility is particularly useful for individuals with conservative longevity expectations or those who prefer regular reassessment appointments. Ellansé-S offers a predictable, adaptable introduction to biostimulation therapy within a manageable treatment timeline.
Ellansé-M
Ellansé-M delivers results lasting approximately two years, balancing extended correction with clinical adaptability.[1] It suits patients who have responded well to shorter-duration biostimulators and are ready to progress, or those seeking fewer treatment sessions without committing to the longest-duration options. Its performance across multiple facial indications makes it one of the most versatile choices in the range, offering a reliable solution for practitioners whose patients are pursuing longer-term rejuvenation with manageable intervals between sessions.
Ellansé-L
Ellansé-L is designed for patients seeking sustained facial rejuvenation over approximately three years.[1] It is appropriate for individuals with stable facial anatomy and consistent aesthetic goals who wish to reduce treatment frequency while maintaining high-quality outcomes. The extended duration makes it well suited to experienced aesthetic patients who have previously demonstrated a predictable collagen response.[2] Ellansé-L supports advanced treatment planning and gives practitioners a dependable option for patients committed to long-term biostimulatory therapy.
Ellansé-E
Ellansé-E is the longest-lasting variant in the range, with a projected duration of up to four years.[1] It is typically reserved for carefully selected patients who have shown positive and predictable collagen responses to prior biostimulatory treatment. Thorough pre-treatment assessment and detailed patient counseling are essential at this duration, as expectation management and suitability criteria are critical for safe and satisfying outcomes. For patients with stable anatomy and long-term aesthetic goals, Ellansé-E offers the maximum longevity among collagen stimulator fillers.[1][5]
Treatment Areas — Where Is Ellansé Used?
- Cheeks and mid-face: Restores volume loss and improves facial support, with both immediate correction and progressive collagen formation contributing to balanced rejuvenation.[2][3]
- Nasolabial folds: Targets underlying structural support rather than surface lines, delivering durable improvement in facial harmony.[1][3]
- Jawline: Enhances lower facial definition and sharpens contours through collagen induction at appropriate tissue depth.[3]
- Chin: Increases projection and supports facial proportions, with results integrating naturally when placed at the correct anatomical plane.[3]
- Temples: Restores lost volume and reduces hollowing, improving lateral facial balance while stimulating collagen for sustained rejuvenation.[3]
- Periorbital region (off-label): Addresses volume deficiencies around the eyes in selected cases; requires experienced technique and precise placement to minimize risk.[3][5]
How Ellansé Works — PCL Collagen Stimulation Explained
Ellansé contains two components that work in sequence. The carboxymethylcellulose (CMC) gel carrier provides immediate structural support at the injection site — an effect that is visible and palpable in the treatment room.[1][2] Over the following weeks, the body gradually resorbs the CMC component while the polycaprolactone (PCL) microspheres remain in place, stimulating a controlled tissue response that activates local fibroblasts and encourages new collagen formation, known as neocollagenesis.[2][4]
As the PCL microspheres slowly biodegrade over months to years — depending on the selected variant — they are progressively replaced by the patient’s own collagen matrix.[1][2] This means results do not simply appear and then diminish. Rather, aesthetic outcomes may continue to improve as collagen remodeling progresses, a characteristic that distinguishes the Ellansé biostimulator from fillers that rely solely on physical volume replacement.[2]
Ellansé is not dissolvable with hyaluronidase. The formulation contains no hyaluronic acid, and this irreversibility must be communicated clearly to patients before treatment proceeds.[5]
Regarding migration: migration risk is low when Ellansé is injected at the correct tissue depth using appropriate technique. Superficial placement increases the risk of adverse events and should be avoided.[3][5]
About Ellansé — Immediate Correction and Long-Term Collagen Stimulation
Ellansé is a next-generation collagen stimulator filler CE-marked for aesthetic use across numerous international markets.[5] It is widely positioned in aesthetic medicine as a meaningful clinical alternative to hyaluronic acid fillers and single-mechanism biostimulators, addressing a distinct patient profile: those who want results that look natural, last longer than standard HA fillers, and continue to refine gradually rather than plateau immediately after injection.[1][4]
The product’s two-component composition drives this differentiation. At injection, the CMC gel delivers instant correction. Over subsequent months, the PCL microspheres progressively stimulate the body’s own collagen production, with the aesthetic result continuing to mature as remodeling progresses.[2][4] The outcome is regenerative rather than purely volumetric — a characteristic that practitioners managing patients with longer-term aesthetic goals consistently identify as clinically valuable.
About the Manufacturer — Sinclair Pharma
Ellansé is developed and manufactured by Sinclair Pharma, an international specialty aesthetic medicine company with a portfolio of CE-marked injectable and topical products used across dermatology and aesthetic practice.[5] Sinclair Pharma’s injectable portfolio includes Ellansé and Perfectha, and the company maintains a focus on clinical evidence across its product lines. Ellansé has accumulated more than two decades of international clinical experience, supported by published peer-reviewed literature evaluating both its safety and long-term efficacy.[1][2][4]
Why Practitioners Choose Ellansé
The four-variant duration system provides genuine longevity flexibility that HA fillers and most single-duration biostimulators cannot match.[1] Practitioners can calibrate how long a result lasts to suit an individual patient’s anatomy, lifestyle, and aesthetic timeline — rather than accepting a fixed degradation schedule. This is a meaningful clinical differentiator for practices managing a diverse patient base. Practitioners buy dermal fillers for many treatment scenarios, and Ellansé’s customizable longevity makes it a substantively different tool from standard filler options.
Furthermore, the dual-action mechanism means outcomes can improve after the treatment session rather than simply appearing and then diminishing over time.[1][2] The immediate correction from the CMC carrier is followed by progressive collagen formation that continues to refine the treated area over months — a quality that patients accustomed to HA-based treatments often find clinically distinctive and worth discussing in consultation.[2]
Administration and Injection Technique
Ellansé should be administered only by trained medical professionals experienced in advanced injectable procedures. The product is intended for deep dermal or subdermal placement, where it provides structural support and stimulates collagen production.[3][5] Superficial placement should be avoided, as incorrect depth increases the risk of visible irregularities, palpable nodules, and other complications.[3][5]
Common injection approaches include linear threading — depositing product along a continuous track as the needle or cannula is withdrawn — and bolus injection, which delivers a concentrated volume at a specific point to restore structure.[3] Many treatments combine both techniques to accommodate individual anatomy and achieve balanced outcomes across the treatment area.
Practitioners should aspirate before injecting to help reduce the risk of vascular complications.[3] Where the technique and treatment area require it, gentle post-injection massage may be recommended to promote even product distribution, in line with the product IFU.[5]
Post-treatment, patients should avoid excessive heat exposure — including saunas, steam rooms, and sunbeds — for 48 to 72 hours, and should limit vigorous physical activity immediately following the session to minimize bruising and swelling. Pressure on treated areas should also be avoided during the initial recovery period to support product integration and maintain the intended result.[5]
Regulatory Status
Ellansé holds CE marking and is authorized for aesthetic use across Europe, the United Kingdom, and numerous other international markets.[5] It is not FDA-approved or FDA-cleared for aesthetic use in the United States, and it is not distributed through standard FDA-regulated commercial channels. Practitioners in the US cannot legally administer Ellansé under its current regulatory status, and this distinction should be communicated clearly to any patients enquiring about treatment.
Addressing a common question directly: Ellansé is not available in the US through standard channels. Regulatory status can also vary by country and by product version, so practitioners in all markets should confirm local requirements, import rules, and professional-use restrictions before ordering or administering the product.[5]
Distribution and Market Availability
Ellansé is available to licensed aesthetic practitioners through authorized wholesale channels across CE-marked markets. Practitioners looking to order or purchase Ellansé for their clinic can browse the full range through Direct Doctor Supply, where all four duration variants are available at competitive wholesale prices with reliable international delivery.
Since 2014, Direct Doctor Supply has supplied licensed aesthetic and medical professionals worldwide with authentic injectable products backed by a dedicated support team, guaranteed delivery, and wholesale deals suited to both single-practice and multi-site procurement needs. The Direct Doctor Supply support team is available to assist with product selection, documentation, and order queries.
Ellansé Safety Profile
Ellansé has a well-characterized safety profile when used in accordance with recommended technique and patient selection criteria.[1][4] Common post-treatment reactions at the injection site include swelling, redness, bruising, and tenderness — effects that are typically transient and resolve without intervention within several days.[4][5]
- Injection-site swelling and redness: mild inflammation as part of the normal tissue response to injection
- Bruising and tenderness: localized and typically resolving within days, more common in vascular facial regions
- Mild discomfort during and immediately after injection: transient soreness that improves quickly in most patients
Nodule formation is uncommon but may occur, most often associated with superficial placement, incorrect injection depth, or inadequate technique — underlining the importance of practitioner training and adherence to protocol.[3][5]
Contraindications include known hypersensitivity to PCL or CMC components, active skin infection or inflammation at the intended treatment site, and pregnancy or breastfeeding. Autoimmune conditions or immunosuppression should be evaluated on a case-by-case basis before treatment.[5]
Because Ellansé cannot be dissolved with hyaluronidase, the irreversible nature of treatment must be explicitly discussed with the patient and documented in the consent process before any injection is performed.[5]
Ellansé vs Other Collagen Stimulators and Fillers
Evaluating Ellansé against comparable products helps practitioners match treatment to patient goals, anatomy, and preference. The key variables are mechanism, longevity, reversibility, and source material.
Ellansé vs Sculptra®
Sculptra® (poly-L-lactic acid) stimulates collagen gradually through a series of sessions, with results appearing over weeks to months — and no immediate correction at the point of injection.[1][4] Ellansé delivers both immediate volumisation via the CMC carrier and progressive neocollagenesis from the PCL microspheres, giving practitioners and patients an outcome that is visible from the first session. For practices that serve patients who benefit from gradual-only biostimulation, buy Sculptra® through Direct Doctor Supply as a complement to Ellansé in a biostimulator-focused treatment menu.
Ellansé vs Radiesse®
Radiesse® uses calcium hydroxylapatite (CaHA) microspheres in a gel carrier, sharing functional similarities with Ellansé’s biostimulatory approach and also providing some immediate correction.[1] The distinguishing factor is duration flexibility: Radiesse® offers a single fixed longevity profile, whereas Ellansé’s four-variant system lets practitioners tailor how long the result lasts.[1][2] Practices seeking to buy Radiesse® for CaHA-based correction can do so alongside Ellansé for patients for whom duration customization is the priority.
Ellansé vs JUVÉDERM®
JUVÉDERM® is a hyaluronic acid filler range designed for volumisation and contour enhancement, with the key clinical advantage of reversibility using hyaluronidase.[5] Unlike Ellansé, JUVÉDERM® does not stimulate long-term collagen production, meaning results diminish as the product degrades. Ellansé provides immediate correction with sustained biostimulation — a different clinical proposition for patients prioritizing durability over reversibility.[1][2] Practitioners can buy JUVÉDERM® on Direct Doctor Supply for patients where HA-based reversibility is the deciding factor.
Ellansé vs RESTYLANE®
RESTYLANE® delivers HA-based volumisation and hydration, with outcomes determined by filler longevity rather than by biostimulation. Ellansé adds a collagen-induction component that extends functional improvement beyond the degradation of its CMC carrier, offering an alternative mechanism for patients seeking progressive change alongside immediate correction.[1][2] Clinics that buy RESTYLANE® alongside Ellansé can offer patients a broader spectrum of injectable approaches within a single practice.
Ellanse vs BELOTERO®
BELOTERO® is an HA filler range developed for precision placement and tissue integration across specific facial indications, with particular strength in fine contouring and superficial correction.[4] Ellansé addresses deeper structural goals through PCL-based collagen stimulation rather than HA volumisation, and the two brands frequently serve different clinical purposes within the same practice. Practitioners who buy BELOTERO® for precision HA correction can integrate Ellansé for patients requiring long-term biostimulatory support at depth.
Direct Doctor Supply has supplied professional-grade aesthetic injectable products to licensed practitioners since 2014, offering wholesale deals, guaranteed delivery, and a dedicated support team for sourcing and documentation assistance. Practitioners looking to buy Ellansé online or wholesale can contact the Direct Doctor Supply support team for product availability, guidance on variant selection, and pricing. Those looking to buy Ellansé dermal filler in volume for recurring clinic use can also enquire about consolidated wholesale arrangements across the full S/M/L/E range.
Frequently Asked Questions
What is Ellansé?
Ellansé is a CE-marked collagen stimulator filler developed by Sinclair Pharma, combining PCL microspheres with a CMC gel carrier to deliver both immediate volumisation and progressive neocollagenesis.[1][4] It is available in four duration variants — S, M, L, and E — allowing practitioners to tailor longevity to individual patient needs and treatment goals.
What is Ellansé made of?
Ellansé contains polycaprolactone (PCL) microspheres suspended in a carboxymethylcellulose (CMC) gel carrier.[1][5] It contains no hyaluronic acid. The CMC component provides immediate volume, while the PCL microspheres stimulate the patient’s own collagen production over time as they gradually biodegrade.
How long does Ellansé last?
Duration depends on the selected variant: Ellansé-S approximately 1 year, Ellansé-M approximately 2 years, Ellansé-L approximately 3 years, and Ellansé-E up to 4 years.[1] Individual longevity can vary based on patient metabolism, lifestyle factors, and treatment area.
Can Ellansé be dissolved?
No. Ellansé contains no hyaluronic acid and cannot be reversed with hyaluronidase.[5] Practitioners must clearly discuss this irreversibility with patients and ensure it is documented during the consent process before treatment proceeds.
Does Ellansé migrate?
Migration risk is low when Ellansé is injected at the correct tissue depth using appropriate technique.[3] Superficial placement increases the risk of irregularities and adverse events, so precise anatomical knowledge and adherence to recommended injection depth are essential.[3][5]
Is Ellansé a filler or a biostimulator?
Ellansé functions as both. The CMC gel provides an immediate filler effect at the point of injection, while the PCL microspheres act as a biostimulator, promoting neocollagenesis over time.[1][4] This dual mechanism — immediate correction alongside progressive collagen formation — positions it as a collagen-stimulating filler rather than as either category alone.
Is Ellansé FDA-approved?
No. Ellansé holds CE marking for use in Europe and a number of international markets but is not FDA-approved or FDA-cleared for aesthetic use in the United States.[5] It is not available through standard US commercial channels, and practitioners in the US should not administer it under its current regulatory status.
Ellansé vs Sculptra® — which is better?
The two products have distinct clinical profiles and suit different patient goals. Ellansé provides immediate correction alongside progressive biostimulation; Sculptra® delivers gradual collagen stimulation across multiple sessions with no immediate volumisation.[1][4] Product choice depends on patient anatomy, timeline expectations, and practitioner experience with each modality.
Looking to buy Ellansé products?
Licensed aesthetic practitioners can access the full Ellansé range — all four duration variants — through the Direct Doctor Supply catalogue, backed by consistent stock availability, wholesale pricing, and worldwide delivery from a supplier that has served verified medical practices since 2014. The Direct Doctor Supply support team can assist with variant selection, documentation, and order inquiries for both new and recurring accounts.
Citations and Resources about Ellansé
[1] Moers-Carpi MM, Sherwood S. Polycaprolactone for the correction of nasolabial folds: a 24-month, prospective, randomized, controlled clinical trial. Dermatologic Surgery. 2013. https://pmc.ncbi.nlm.nih.gov/articles/PMC3615178/
[2] Angelo-Khattar M. Objective assessment of the long-term volumizing action of a polycaprolactone-based filler. Clinical, Cosmetic and Investigational Dermatology. 2022. https://pmc.ncbi.nlm.nih.gov/articles/PMC9805706/
[3] de Melo F, Nicolau P, Piovano L, et al. Recommendations for volume augmentation and rejuvenation of the face and hands with the new generation polycaprolactone-based collagen stimulator (Ellansé®). Clinical, Cosmetic and Investigational Dermatology. 2017. https://pmc.ncbi.nlm.nih.gov/articles/PMC5685142/
[4] Christen MO, Vercesi F. How a well-known and futuristic polymer has become an innovative collagen-stimulator in esthetics. Clinical, Cosmetic and Investigational Dermatology. 2020. https://pubmed.ncbi.nlm.nih.gov/32161484/
[5] Sinclair Pharma. Ellansé® Summary of Safety and Clinical Performance (SSCP). https://sinclair.com/media/dzunuwow/e-mdd-sscp-02-ellanse-mdd-sscp_digital-version-copy.pdf
All content on this website is intended for informational purposes only and does not constitute medical advice.
Content prepared by Direct Doctor Supply’s editorial team.
Sourcing and accuracy for this page follow our Editorial Policy: claims are cross-checked against clinical literature, regulatory filings, and manufacturer specifications before anything is published.

